Prospectus
Filed with ASX · · 39 pages · English
Summary by 6ix AI
Biotron Limited has filed a prospectus for a renounceable rights issue to raise funds by offering new shares to eligible shareholders. The offer is partially underwritten, and shareholders are encouraged to read the entire document for important details and risks associated with the investment.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/prospectus-104
Story so far
Earlier from Biotron
- Renounceable Rights Issue
- Updated Appendix 4C
- Agreement with C14 Consulting Group
- $1.8M R&D Rebate Received
- BIT225-012 Phase 2 COVID-19 clinical trial
Later from Biotron
- Response to ASX Aware Query
- Supplementary Prospectus
- Response to ASX Query Letter
- Replacement Prospectus
- Rights Issue Closed
Follow Biotron into a list and get an email when it puts out news.
Follow Biotron